General Investing >> Analyst Interviews >> May 13, 2003
Dr. Juan Sanchez is an Associate of the equity research team at Punk,
Ziegel & Company, covering the biotechnology and nanotechnology sectors.
He has more than five years of experience in clinical medical practice.
He has a background in the pharmaceutical industry as well as in science
and technology assessment at Columbia University. He holds an MIA degree
from Columbia University, an MBA from the University of Los Andes and an
MD from Javeriana University. Profile
of nanotechnology today?
Dr. Sanchez: Punk, Ziegel & Company is a full service brokerage firm
that was founded in
